Thomas Nerreter
Wuerzburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
A universally applicable toolbox for single-molecule quantification of chimeric antigen receptors using linker-resolved dSTORM microscopy.
Journal: Frontiers in immunology
Published: June 01, 2026
Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity.
Journal: Journal for immunotherapy of cancer
Published: May 12, 2026
Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma.
Journal: Leukemia
Published: August 06, 2025
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.
Journal: Nature communications
Published: June 11, 2025
Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.
Journal: Molecular therapy. Oncology
Published: April 22, 2025
Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 27, 2025
Decoding the molecular interplay of CD20 and therapeutic antibodies with fast volumetric nanoscopy.
Journal: Science (New York, N.Y.)
Published: January 09, 2025
ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice.
Journal: Cell reports. Medicine
Published: December 05, 2024
Correction: ROR1-targeting switchable CAR-T cells for cancer therapy.
Journal: Oncogene
Published: February 21, 2024
Last Updated: 09/26/2026